<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-145596" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>EBV-Associated Myopericarditis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Das</surname>
            <given-names>Rakesh</given-names>
          </name>
          <aff>Lincoln medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Nguyen</surname>
            <given-names>Andrew D.</given-names>
          </name>
          <aff>University of Queensland, University of Western Australia</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Rakesh Das declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Andrew Nguyen declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>11</day>
          <month>1</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-145596.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Epstein-Barr virus (EBV) is a widely distributed virus from the herpesvirus family (human herpesvirus 4), containing a double-stranded DNA core enclosed by proteins.<xref ref-type="bibr" rid="article-145596.r1">[1]</xref>&#x000a0;EBV spreads through close contact between susceptible individuals and asymptomatic carriers of EBV. The primary source of virus transmission is through bodily fluids, primarily saliva.<xref ref-type="bibr" rid="article-145596.r2">[2]</xref>&#x000a0;Instances of spread&#x000a0;are documented in the context of stem cell and organ transplantation and blood transfusion.<xref ref-type="bibr" rid="article-145596.r3">[3]</xref>&#x000a0;EBV can cause aggressive and catastrophic diseases in immunocompromised individuals, like chronic&#x000a0;EBV disease, hemophagocytic lymphohistiocytosis,&#x000a0;autoimmune phenomena, and some tumors (Hodgkin lymphoma, non-Hodgkin lymphoma, nasopharyngeal cancer, and Burkitt lymphoma).<xref ref-type="bibr" rid="article-145596.r4">[4]</xref><xref ref-type="bibr" rid="article-145596.r5">[5]</xref></p>
        <p>Cardiovascular manifestations and sequelae from&#x000a0;EBV infection are less common yet significant, resulting from direct toxicity (lysing of host cells or cleavage of host proteins by viral proteases) and immune-mediated cellular injury. These complications have been noted in individuals whose immune systems are compromised. Complications include dilatation of the coronary artery, aneurysm of the coronary artery, progression of coronary artery disease, myopericarditis, valvular disease, and pulmonary hypertension, among others.<xref ref-type="bibr" rid="article-145596.r6">[6]</xref>&#x000a0;If not managed promptly and appropriately, fatal outcomes can occur.<xref ref-type="bibr" rid="article-145596.r7">[7]</xref></p>
      </sec>
      <sec id="article-145596.s2" sec-type="Etiology">
        <title>Etiology</title>
        <p>EBV has an outer layer of glycoproteins. These are essential for binding to and infiltrating specific host cells, primarily B-cells and epithelial cells.<xref ref-type="bibr" rid="article-145596.r8">[8]</xref>&#x000a0;EBV&#x000a0;mutates B-cells to duplicate genetic material. This process converts B-cells into memory B-cells, which can circulate in the bloodstream or remain inactive until an external trigger prompts&#x000a0;the revival.<xref ref-type="bibr" rid="article-145596.r9">[9]</xref></p>
        <p>B lymphocytes, T lymphocytes, epithelial cells, and myocytes&#x000a0;are host cells for EBV. Unlike herpes simplex (HSV) or cytomegalovirus (CMV), EBV transforms B-cells&#x000a0;without causing&#x000a0;noticeable cell damage.<xref ref-type="bibr" rid="article-145596.r10">[10]</xref>&#x000a0;Given the latency of EBV, host factors such as immunosuppression may lead to virus reactivation, leading to clinical manifestations such as infectious mononucleosis and autoimmune phenomena.<xref ref-type="bibr" rid="article-145596.r8">[8]</xref><xref ref-type="bibr" rid="article-145596.r11">[11]</xref><xref ref-type="bibr" rid="article-145596.r12">[12]</xref><xref ref-type="bibr" rid="article-145596.r13">[13]</xref>&#x000a0;Immunosuppression is associated with aggressive lymphoproliferative disorders in organ transplant recipients and other immunocompromised patients, first described in observations of EBV within tissue samples of lymphoma patients.<xref ref-type="bibr" rid="article-145596.r8">[8]</xref><xref ref-type="bibr" rid="article-145596.r14">[14]</xref></p>
      </sec>
      <sec id="article-145596.s3" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Approximately 90% to 95% of the global adult population has experienced&#x000a0;EBV infection.<xref ref-type="bibr" rid="article-145596.r15">[15]</xref>&#x000a0;In the United States, one seroprevalence study estimated the prevalence of EBV among children and adolescents aged 6 to 19 to be 66.5%.<xref ref-type="bibr" rid="article-145596.r16">[16]</xref>&#x000a0;Specifically, children aged 6 to 8 exhibited an approximate 54% prevalence, while adolescents aged 18 to 19 displayed a prevalence of 82.9%. The Mexican-American children and adolescents in the study exhibited a higher EBV prevalence in comparison to their non-Hispanic black and white counterparts. In low and middle-income countries, the estimated population seroprevalence of EBV ranged from 92.1% to 94.8%, with the highest seropositivity in those aged &#x0003e;40 years.<xref ref-type="bibr" rid="article-145596.r17">[17]</xref>&#x000a0;In the United Kingdom, a seroprevalence study estimated an overall population prevalence of 85.3%, with females reaching seropositivity younger than males.<xref ref-type="bibr" rid="article-145596.r18">[18]</xref>&#x000a0;</p>
        <p>Other findings included higher seroprevalence in those with a white ethnicity, lower body mass index, and a non-smoking history. Factors such as larger household sizes, lower household incomes, decreased parental education, early life maternal deprivation, and foreign birth are all associated with a heightened prevalence of EBV infection among children and adolescents.<xref ref-type="bibr" rid="article-145596.r19">[19]</xref><xref ref-type="bibr" rid="article-145596.r16">[16]</xref></p>
        <p>Myopericarditis is infrequent in children and adolescents, with a projected occurrence rate of 1 to 2 cases per 100,000 individuals.<xref ref-type="bibr" rid="article-145596.r20">[20]</xref>&#x000a0;In cases of EBV associated with coronary disease, evidence is limited to observational studies or case reports, with one study of 299 patients with percutaneous coronary intervention indicating higher measures of pro-inflammatory cytokines and EBV-related proteins among all patients with acute myocardial infarctions.<xref ref-type="bibr" rid="article-145596.r21">[21]</xref>&#x000a0;In an anatomical study of 142 patients with cardiac dilation and histological evidence of myocarditis, 9&#x000a0;patients were found&#x000a0;positive for EBV DNA.<xref ref-type="bibr" rid="article-145596.r22">[22]</xref></p>
      </sec>
      <sec id="article-145596.s4" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The progression of viral myocarditis-induced damage unfolds in&#x000a0;2 distinct phases. The initial phase spans roughly&#x000a0;1 week and is characterized by viral infiltration into the myocardium, viral replication, and subsequent cell lysis. Neutralizing antibodies are generated, leading to the elimination or attenuation of the virus by macrophages and natural killer cells during the innate immune response.<xref ref-type="bibr" rid="article-145596.r23">[23]</xref><xref ref-type="bibr" rid="article-145596.r24">[24]</xref></p>
        <p>Following this stage, the myocardium experiences an influx of inflammatory cells, accompanied by immune system activation that includes the production of antibodies targeting cardiac myocytes through an adaptive immune response driven by T cells. This phase endures for several weeks or months and is associated with varying extents of myocardial impairment, ranging from minimal to severe. Recovery may occur with the elimination of pathogens, but in susceptible individuals such as those with immune dysfunction, chronic inflammation, remodeling, dilated cardiomyopathy, and cardiac failure may occur.<xref ref-type="bibr" rid="article-145596.r24">[24]</xref>&#x000a0;In the murine model, characteristic pathological findings encompass multiple localized regions of myocyte loss, sheets of fibrosis, and diffusely scattered calcified deposits throughout all layers and chambers of the cardiac muscle.<xref ref-type="bibr" rid="article-145596.r23">[23]</xref></p>
      </sec>
      <sec id="article-145596.s5" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Pathologically, inflammatory cell infiltrates associated with or without myocyte necrosis are required to identify myocarditis when viewing stained heart tissue sections.<xref ref-type="bibr" rid="article-145596.r25">[25]</xref>&#x000a0;Autoantibodies to cardiac antigens, such as cardiac myosin, may be performed. Based on the associated clinical history and prodrome, findings may be consistent with either fulminant lymphocytic myocarditis or acute lymphocytic myocarditis.<xref ref-type="bibr" rid="article-145596.r26">[26]</xref>&#x000a0;Therefore, findings may suggest a viral etiology on histopathology. A concordant clinical history is required to confirm viral myocarditis.</p>
      </sec>
      <sec id="article-145596.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The clinical presentation encompasses asymptomatic conditions to abrupt fatality attributable to either fulminant heart failure or malignant ventricular arrhythmias. The clinical presentation holds notable prognostic significance, and individuals with heart failure symptoms at the outset are markedly prone to requiring transplantation and facing cardiac mortality.<xref ref-type="bibr" rid="article-145596.r27">[27]</xref></p>
        <p>Symptoms mostly resemble a cold, including fever, fatigue, cough, and odynophagia. Other symptoms encompass precordial chest pain, palpitations, polymyalgia, and asthenia.<xref ref-type="bibr" rid="article-145596.r28">[28]</xref>&#x000a0;Additionally, there is mild, non-radiating chest discomfort, breathlessness, dizziness, and decreased ability to exercise, all absent during rest.<xref ref-type="bibr" rid="article-145596.r29">[29]</xref>&#x000a0;The emergence of myocarditis in children and adults might be preceded by a viral prodrome characterized by symptoms like rash, myo-arthralgias, and gastrointestinal and respiratory issues, occurring anywhere from several days to a few weeks prior.<xref ref-type="bibr" rid="article-145596.r30">[30]</xref><xref ref-type="bibr" rid="article-145596.r24">[24]</xref><xref ref-type="bibr" rid="article-145596.r31">[31]</xref></p>
        <p>In cases where pericardial involvement is predominant, individuals may describe the pain as sharp, exacerbated by coughing or deep breaths, and alleviated by assuming a forward-leaning position. When there is substantial myocardial engagement, the pain might be continuous, posing challenges while distinguishing it from myocardial ischemic pain, particularly among those with cardiovascular risk factors.<xref ref-type="bibr" rid="article-145596.r32">[32]</xref>&#x000a0;Additionally, they might exhibit prevalent symptoms of heart failure like breathlessness, orthopnea, swelling in the lower extremities, and fatigue. Infrequent symptoms encompass arrhythmias, syncope, and sudden cardiac arrest.<xref ref-type="bibr" rid="article-145596.r33">[33]</xref></p>
        <p>Physical examination findings can vary but commonly include fever, a pericardial friction rub, and indications of heart failure. <xref ref-type="bibr" rid="article-145596.r34">[34]</xref>&#x000a0;Furthermore, enlarged cervical lymph nodes and tonsillar hypertrophy with exudates&#x000a0;are present. Conversely, symptoms like hepatomegaly and splenomegaly are notably absent. Manifestations of systemic illness that might contribute to the underlying cause include autoimmune disorders, systemic lupus erythematosus, vaccinations, chemotherapy, and immune checkpoint inhibitor therapy.<xref ref-type="bibr" rid="article-145596.r35">[35]</xref><xref ref-type="bibr" rid="article-145596.r36">[36]</xref></p>
        <p>These subtle presentations can sometimes lead to complications abruptly, escalating into life-threatening scenarios. Myopericarditis exhibits diverse progression patterns, ranging from fatal outcomes attributed to severe systolic dysfunction or ventricular arrhythmias to extended development into dilated cardiomyopathy.<xref ref-type="bibr" rid="article-145596.r37">[37]</xref>&#x000a0;Upon&#x000a0;discharge from inpatient care, vigilant monitoring for several weeks&#x000a0;is imperative, especially in cases where the possibility of heart failure development persists.</p>
      </sec>
      <sec id="article-145596.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>
<bold>Laboratory Studies</bold>
</p>
        <p>Atypical lymphocytosis is typically evident in peripheral smears.<xref ref-type="bibr" rid="article-145596.r8">[8]</xref>&#x000a0;Serological testing is generally used to ascertain whether a patient has exposure to EBV. Routine viral serology tests are not typically beneficial for the diagnostic process, as their outcomes seldom influence treatment decisions. In determining acute infection with EBV, a heterophile antibody test can detect immunoglobulin M (IgM) antibodies targeting EBV. False positive results may occur due to the cross-reactivity of IgM with other viral infections, hematological malignancies, and autoimmune disorders.<xref ref-type="bibr" rid="article-145596.r38">[38]</xref>&#x000a0;Despite these caveats, utilizing heterophile antibody testing as an initial approach is advantageous due to&#x000a0;the affordability, rapidity, and sensitivity range of 63% to 84% and specificity range of 84% to 100%.<xref ref-type="bibr" rid="article-145596.r39">[39]</xref>&#x000a0;</p>
        <p>Given the challenges of using serological markers to diagnose EBV infection, polymerase chain reaction (PCR) methods have been demonstrated to accurately detect primary EBV infection and reactivation in sera without heterophile antibodies.<xref ref-type="bibr" rid="article-145596.r38">[38]</xref>&#x000a0;Sensitivity and specificity among pediatric populations with infectious mononucleosis were 77% (95% CI 66-86%) and specificity 98% (95% CI 93-100%) respectively.<xref ref-type="bibr" rid="article-145596.r40">[40]</xref>&#x000a0;Furthermore, PCR may be applied to paraffin-embedded tissues with assay sensitivities as low as 50 copies of EBV DNA per reaction.<xref ref-type="bibr" rid="article-145596.r41">[41]</xref>&#x000a0;PCR has replaced culture as the primary means of detecting EBV in tissue.<xref ref-type="bibr" rid="article-145596.r42">[42]</xref></p>
        <p>Myopericarditis can result in elevated levels of inflammatory markers, including erythrocyte sedimentation rate, C-reactive protein, white blood cells, and cardiac biomarkers.<xref ref-type="bibr" rid="article-145596.r43">[43]</xref>&#x000a0;A comprehensive blood analysis is recommended for all patients to rule out thyroid disorders and hepatitis and assess renal function. This approach thoroughly evaluates the patient's overall health and contributing factors.<xref ref-type="bibr" rid="article-145596.r44">[44]</xref>&#x000a0;</p>
        <p>
<bold>Electrocardiogram</bold>
</p>
        <p>Characteristic electrocardiogram patterns in pericarditis encompass a widespread, concave elevation of ST segments and PR depression. These alterations, generalized T-wave modifications, or inversions can vary depending on the extent of myocardial engagement. While ST-segment alterations are generally diffuse, localized ECG shifts (inferolateral or anterolateral) can also manifest contingent on the degree of involvement. Frequent arrhythmias involve supraventricular or ventricular ectopic beats and brief episodes of ventricular arrhythmias.<xref ref-type="bibr" rid="article-145596.r45">[45]</xref><xref ref-type="bibr" rid="article-145596.r46">[46]</xref></p>
        <p>
<bold>Chest Radiography</bold>
</p>
        <p>Pericardial effusion may manifest as a rounded cardiac silhouette on a chest X-ray. Echocardiography&#x000a0;typically confirms&#x000a0;effusion, constriction, or tamponade.<xref ref-type="bibr" rid="article-145596.r47">[47]</xref></p>
        <p>
<bold>Echocardiogram</bold>
</p>
        <p>The echocardiographic characteristics of myocarditis are non-specific. However, as a part of the routine evaluation, an echocardiogram is ordered, which may reveal normal heart function along with a minimal or absent pericardial effusion. The echocardiographic presentation can resemble various patterns, including dilated, hypertrophic, restrictive, or right ventricular cardiomyopathy, along with manifestations similar to coronary artery disease. Additionally, the echocardiogram assesses the functioning of both the left and right ventricles and identifies any abnormalities related to valvular heart disease.<xref ref-type="bibr" rid="article-145596.r48">[48]</xref></p>
        <p>
<bold>Coronary Angiography</bold>
</p>
        <p>When there is suspicion of acute coronary syndrome, and the clinical presentation is reminiscent of coronary artery disease, this diagnostic approach is considered the definitive method to exclude its presence. In cases where traditional contraindications are not applicable, CT coronary angiography (CTCA) might be an alternative. For young patients exhibiting typical myopericarditis symptoms, coronary angiography is typically unnecessary. However, for individuals with risk factors associated with atherosclerotic cardiovascular disease, distinguishing between myopericarditis and myocardial ischemia through non-invasive testing&#x000a0;is challenging. In such instances, cardiac catheterization is required to rule out acute coronary syndrome.<xref ref-type="bibr" rid="article-145596.r49">[49]</xref><xref ref-type="bibr" rid="article-145596.r44">[44]</xref></p>
        <p>
<bold>Cardiac Magnetic Resonance Imaging</bold>
</p>
        <p>Cardiac MRI&#x000a0;is a promising technique for assessing individuals suspected of having myocarditis. The revised Lake Louis criteria now encompass T1 and T2 criteria for diagnosing myocarditis. T1 imaging reveals an elevated T1 relaxation time, while T2 imaging demonstrates an increased T2 relaxation time or Signal Intensity (SI). In addition, gadolinium-enhanced CMR sequences unveil irregular hyperenhancement patterns within the myocardial tissue.<xref ref-type="bibr" rid="article-145596.r50">[50]</xref>&#x000a0;Such changes&#x000a0;are associated with a higher rate of mortality, including sudden cardiac death.<xref ref-type="bibr" rid="article-145596.r51">[51]</xref></p>
        <p>
<bold>Endomyocardial Biopsy</bold>
</p>
        <p>Endomyocardial biopsy (EMB) is warranted in select cases of severely ill patients who demonstrate clinical deterioration&#x000a0;after standard supportive treatment.&#x000a0;EMB is the gold standard for diagnosis. According to the consensus scientific statement of the European Society of Cardiology, the American Heart Association, and the American College of Cardiology, a class I indication for performing EMB in myocarditis is in cases of new-onset heart failure lasting less than&#x000a0;2 weeks, involving preserved ventricle dimensions but compromised hemodynamics.<xref ref-type="bibr" rid="article-145596.r52">[52]</xref>&#x000a0;Additionally, EMB is indicated as a class I procedure for patients experiencing new-onset heart failure lasting&#x000a0;2 weeks to 3 months, characterized by dilated ventricles, tachyarrhythmia or bradyarrhythmia, and a lack of response to therapy within 1 to 2 weeks.<xref ref-type="bibr" rid="article-145596.r53">[53]</xref></p>
      </sec>
      <sec id="article-145596.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>For the majority of patients, the overall prognosis of this condition is favorable, and long-term complications are rare. The available data to inform the management of myopericarditis are currently limited.<xref ref-type="bibr" rid="article-145596.r54">[54]</xref>&#x000a0;Viral myopericarditis is mainly supportive and follows the general management of myopericarditis.&#x000a0;</p>
        <p>
<bold>Hemodynamically Unstable Patients</bold>
</p>
        <p>Patients presenting with a life-threatening condition should be directed to specialized facilities equipped with the capacity for hemodynamic monitoring, cardiac catheterization, expertise in EMB, and cardiac surgery. In instances of hemodynamic instability, the implementation of a mechanical cardio-pulmonary assist device&#x000a0;is necessary to bridge either recovery or heart transplantation.<xref ref-type="bibr" rid="article-145596.r55">[55]</xref>&#x000a0;The consideration for cardiac transplantation should be postponed during the acute phase, as there is a potential for spontaneous recovery. However, this option&#x000a0;is considered&#x000a0;for hemodynamically unstable myocarditis patients, including those with giant cell myocarditis, if optimal pharmacological support and mechanical assistance fail to stabilize the patient.<xref ref-type="bibr" rid="article-145596.r56">[56]</xref></p>
        <p>
<bold>Hemodynamically Stable Patients&#x000a0;</bold>
</p>
        <p>For patients experiencing stable heart failure, the recommended treatment includes diuretics, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and beta-adrenergic blockers. If individuals continue to show symptoms of heart failure despite receiving optimal care, one should consider adding aldosterone antagonists.<xref ref-type="bibr" rid="article-145596.r57">[57]</xref>&#x000a0;</p>
        <p>When the initial manifestation resembles pericarditis symptoms, and the left ventricular function remains intact, the first-line treatment involves Nonsteroidal anti-inflammatory drugs (NSAIDs). However, in cases where substantial myocardial involvement is evident, NSAIDs&#x000a0;are approached cautiously due to their potential to exacerbate myocardial function and cardiac failure.<xref ref-type="bibr" rid="article-145596.r58">[58]</xref>&#x000a0;In such instances, NSAIDs are administered at minimal dosages to avoid compromising myocardial health.<xref ref-type="bibr" rid="article-145596.r44">[44]</xref></p>
        <p>
<bold>Arrhythmia</bold>
</p>
        <p>Ventricular or atrial arrhythmias and heart block are potential complications of acute myocarditis. In hemodynamically stable tachyarrhythmia without signs of peripheral hypoperfusion, &#x003b2;-blocker therapy is advised. Patients with sustained ventricular arrhythmias&#x000a0;are recommended amiodarone and dofetilide as suitable treatment options. When necessary, heart block is addressed by implementing a temporary pacemaker followed by a permanent pacemaker. As the acute phase subsides, standard recommendations&#x000a0;include an implantable cardioverter defibrillator during the chronic stage.<xref ref-type="bibr" rid="article-145596.r49">[49]</xref></p>
        <p><bold>Avoidance of Exercise</bold>&#x000a0;</p>
        <p>During acute myocarditis, physical activity should be restricted. Patients are discouraged from engaging in competitive sports for at least 3 to&#x000a0;6 months following the acute episode. Subsequent guidance hinges on regular follow-up involving clinical evaluation, echocardiography, and Holter monitoring.<xref ref-type="bibr" rid="article-145596.r59">[59]</xref><xref ref-type="bibr" rid="article-145596.r60">[60]</xref></p>
        <p>
<bold>Immunomodulatory Therapy</bold>
</p>
        <p>There is no approved antiviral therapy, but vaccination is a future possibility.<xref ref-type="bibr" rid="article-145596.r61">[61]</xref></p>
        <p>In cases of myocarditis that do not respond to standard heart failure treatments, including both viral and autoimmune types, especially those driven by autoantibodies, intravenous immunoglobulin (IVIG) may be employed&#x000a0;to minimize adverse effects.<xref ref-type="bibr" rid="article-145596.r62">[62]</xref></p>
        <p>
<bold>Immunosuppressive Therapy</bold>
</p>
        <p>The safety and effectiveness of immunosuppressive regimens for myocarditis&#x000a0;are studied using steroids alone, combined with azathioprine or cyclosporine A, azathioprine, and steroids. Limited information is available regarding the use of other medications. Reports on treatment outcomes primarily focus on chronic cases that are negative for viral involvement.<xref ref-type="bibr" rid="article-145596.r56">[56]</xref></p>
      </sec>
      <sec id="article-145596.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p><bold>Acute Coronary Syndrome</bold>&#x000a0;</p>
        <p>Cardiovascular magnetic resonance imaging is vital in distinguishing between different causes of acute coronary syndromes. This significance&#x000a0;is pronounced due to the vague and overlapping signs and symptoms, which resemble those of other conditions like myopericarditis.<xref ref-type="bibr" rid="article-145596.r63">[63]</xref>&#x000a0;The viral prodrome of EBV-associated myocarditis&#x000a0;rules out acute coronary syndrome.</p>
        <p>
<bold>Chagas Heart Disease (CHD)</bold>
</p>
        <p>As a result of the protozoan parasite Trypanosoma cruzi, CHD&#x000a0;is the primary cause of known infectious myocarditis globally, albeit concentrated within the Americas.<xref ref-type="bibr" rid="article-145596.r64">[64]</xref>&#x000a0;CHD comprises&#x000a0;2 distinct clinical phases: the acute phase, which emerges shortly following infection and persists for 4 to 8 weeks, and the chronic phase, which evolves over 10 to 30 years. The PCR is the most sensitive diagnostic tool in the acute phase of Chagas disease.<xref ref-type="bibr" rid="article-145596.r65">[65]</xref>&#x000a0;In around one-third of cases, the chronic phase develops from asymptomatic to symptomatic.</p>
        <p>
<bold>Cardiac Tamponade</bold>
</p>
        <p>Pericarditis frequently involves pericardial effusion, which&#x000a0;could progress to cardiac tamponade.<xref ref-type="bibr" rid="article-145596.r66">[66]</xref>&#x000a0;Cardiac tamponade is a condition that arises when there is a sudden and excessive buildup of fluid within the pericardial cavity.&#x000a0;</p>
      </sec>
      <sec id="article-145596.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Differentiating acute myopericarditis from pericarditis is essential. Common viruses, including parvovirus B19, adenovirus, herpes viruses, hepatitis viruses, human immunodeficiency virus, and enteroviruses, can induce heart inflammation,&#x000a0;leading to&#x000a0;acute pericarditis and myocarditis.<xref ref-type="bibr" rid="article-145596.r67">[67]</xref>&#x000a0;EBV&#x000a0;rarely contributes to&#x000a0;these conditions&#x000a0;in individuals with intact immune systems.<xref ref-type="bibr" rid="article-145596.r13">[13]</xref>&#x000a0;The prognosis can be jeopardized by heart failure, particularly in cases of severe onset. Due to the diverse clinical manifestations of EBV, the severity of such manifestations, and the interplay with host immune factors, the prognosis of EBV-related myopericarditis can vary. In general, patients experiencing acute decompensated heart failure, persistent arrhythmias, and a left ventricular ejection fraction below 50%, or those necessitating inotropic agents, vasopressors, or mechanical cardiac assistance, are more likely to encounter unfavorable cardiovascular outcomes.<xref ref-type="bibr" rid="article-145596.r68">[68]</xref><xref ref-type="bibr" rid="article-145596.r69">[69]</xref></p>
      </sec>
      <sec id="article-145596.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications may vary according to the interplay between EBV and the host immune system, but known sequelae of viral (including EBV) related cardiac manifestations include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Coronary artery dilatation<xref ref-type="bibr" rid="article-145596.r70">[70]</xref></p>
          </list-item>
          <list-item>
            <p>Coronary artery aneurysm<xref ref-type="bibr" rid="article-145596.r71">[71]</xref></p>
          </list-item>
          <list-item>
            <p>Valvular heart disease<xref ref-type="bibr" rid="article-145596.r72">[72]</xref></p>
          </list-item>
          <list-item>
            <p>Acute myocardial infarction<xref ref-type="bibr" rid="article-145596.r21">[21]</xref></p>
          </list-item>
          <list-item>
            <p>Pulmonary arterial hypertension<xref ref-type="bibr" rid="article-145596.r73">[73]</xref></p>
          </list-item>
          <list-item>
            <p>Left ventricle dysfunction<xref ref-type="bibr" rid="article-145596.r24">[24]</xref></p>
          </list-item>
          <list-item>
            <p>Right ventricle failure<xref ref-type="bibr" rid="article-145596.r74">[74]</xref></p>
          </list-item>
          <list-item>
            <p>Arrhythmia<xref ref-type="bibr" rid="article-145596.r33">[33]</xref></p>
          </list-item>
          <list-item>
            <p>Death secondary to the above</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-145596.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients with EBV infection should be informed about potential complications, which range from asymptomatic conditions to life-threatening outcomes such as coronary artery dilation, valvular heart disease, and heart failure.<xref ref-type="bibr" rid="article-145596.r6">[6]</xref>&#x000a0;However, these fatal complications can be prevented with prompt and appropriate management. Transmission of EBV occurs primarily through close contact with infected individuals, mainly saliva.<xref ref-type="bibr" rid="article-145596.r2">[2]</xref>&#x000a0;Regular&#x000a0;precautions that include awareness and personal hygiene&#x000a0;prevent viral transmission.&#x000a0;</p>
        <p>Patients who develop myopericarditis and are hemodynamically unstable must have a timely referral to a highly specialized cardiac center. Other patients should receive symptomatic management following the principles of heart failure treatment. Patients with heart failure are more susceptible to unfavorable cardiac complications,&#x000a0;so close monitoring and proper medical care are crucial. Timely and thorough&#x000a0;cardiac evaluation&#x000a0;is paramount to detecting potential complications and providing appropriate interventions.&#x000a0;</p>
        <p>In summary, educating patients about the potential complications of EBV infection, emphasizing the importance of transmission prevention, ensuring timely referrals for severe cases, and implementing appropriate management strategies can contribute to better outcomes and a reduced risk of complications.</p>
      </sec>
      <sec id="article-145596.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Patients with EBV-associated myocarditis face a significant risk of mortality when not promptly and effectively treated. Therefore, early management&#x000a0;is crucial for reducing morbidity and mortality. The care of individuals with EBV-associated myocarditis demands a collaborative approach involving healthcare professionals to provide patient-centered care and enhance overall outcomes.</p>
        <p>A multidisciplinary team, including cardiologists, emergency medicine clinicians, critical care clinicians, advanced practitioners, nurses, pharmacists, physiotherapists, and other healthcare providers, should possess the clinical skills and knowledge to diagnose and manage EBV-associated myocarditis.&#x000a0;The condition involves expertise in recognizing diverse clinical presentations and proficiency in diagnostic techniques such as echocardiography, cardiac MRI, and endomyocardial biopsy.<xref ref-type="bibr" rid="article-145596.r75">[75]</xref><xref ref-type="bibr" rid="article-145596.r76">[76]</xref>&#x000a0;Furthermore, educating patients and caregivers about the condition's origins, symptoms, and utilization of diagnostic tools is vital in preventing cardiac complications and reducing morbidity.</p>
        <p>A strategic approach involving evidence-based strategies to optimize treatment plans while minimizing adverse effects is crucial. Ethical considerations should steer decision-making, ensuring that informed consent is secured and patient autonomy is honored in the decision-making process. Every healthcare professional should be conscious of their responsibilities and contribute unique expertise to the patient's care plan, fostering a multidisciplinary approach.</p>
        <p>Effective interprofessional communication is paramount, allowing for seamless information exchange and collaborative decision-making among team members. Care coordination&#x000a0;is vital in ensuring that the patient's path from diagnosis to treatment and follow-up is effectively managed, minimizing errors and improving patient safety.&#x000a0;By embracing these principles of skill, strategy, ethics, responsibilities, interprofessional communication, and care coordination, healthcare professionals can deliver integrated patient-centered care.</p>
      </sec>
      <sec id="article-145596.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=145596&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=145596">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/ebv-associated-myopericarditis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=145596">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/145596/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=145596">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-145596.s15">
        <title>References</title>
        <ref id="article-145596.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Zuo</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Zuo</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Epstein-Barr Virus and Neurological Diseases.</article-title>
            <source>Front Mol Biosci</source>
            <year>2021</year>
            <volume>8</volume>
            <fpage>816098</fpage>
            <pub-id pub-id-type="pmid">35083281</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Castillo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Giraldo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Guzm&#x000e1;n</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bravo</surname>
                <given-names>LE</given-names>
              </name>
            </person-group>
            <article-title>Factors associated with the presence of the Epstein-Barr virus in the oral cavity of high school students from the city of Cali (Colombia).</article-title>
            <source>Enferm Infecc Microbiol Clin (Engl Ed)</source>
            <year>2022</year>
            <month>Mar</month>
            <volume>40</volume>
            <issue>3</issue>
            <fpage>113</fpage>
            <page-range>113-120</page-range>
            <pub-id pub-id-type="pmid">35000871</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dunmire</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Verghese</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Balfour</surname>
                <given-names>HH</given-names>
              </name>
            </person-group>
            <article-title>Primary Epstein-Barr virus infection.</article-title>
            <source>J Clin Virol</source>
            <year>2018</year>
            <month>May</month>
            <volume>102</volume>
            <fpage>84</fpage>
            <page-range>84-92</page-range>
            <pub-id pub-id-type="pmid">29525635</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nowalk</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Green</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Epstein-Barr Virus.</article-title>
            <source>Microbiol Spectr</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>4</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">27337443</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Houen</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Trier</surname>
                <given-names>NH</given-names>
              </name>
            </person-group>
            <article-title>Epstein-Barr Virus and Systemic Autoimmune Diseases.</article-title>
            <source>Front Immunol</source>
            <year>2020</year>
            <volume>11</volume>
            <fpage>587380</fpage>
            <pub-id pub-id-type="pmid">33488588</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Muneuchi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ohga</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ishimura</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ikeda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yamaguchi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nomura</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Takada</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Abe</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hara</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Cardiovascular complications associated with chronic active Epstein-Barr virus infection.</article-title>
            <source>Pediatr Cardiol</source>
            <year>2009</year>
            <month>Apr</month>
            <volume>30</volume>
            <issue>3</issue>
            <fpage>274</fpage>
            <page-range>274-81</page-range>
            <pub-id pub-id-type="pmid">19184184</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Deng</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zhong</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Xiao</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Cardiovascular involvement in Epstein-Barr virus infection.</article-title>
            <source>Front Immunol</source>
            <year>2023</year>
            <volume>14</volume>
            <fpage>1188330</fpage>
            <pub-id pub-id-type="pmid">37292213</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Odumade</surname>
                <given-names>OA</given-names>
              </name>
              <name>
                <surname>Hogquist</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Balfour</surname>
                <given-names>HH</given-names>
              </name>
            </person-group>
            <article-title>Progress and problems in understanding and managing primary Epstein-Barr virus infections.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>2011</year>
            <month>Jan</month>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>193</fpage>
            <page-range>193-209</page-range>
            <pub-id pub-id-type="pmid">21233512</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sarwari</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Khoury</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Hernandez</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Chronic Epstein Barr virus infection leading to classical Hodgkin lymphoma.</article-title>
            <source>BMC Hematol</source>
            <year>2016</year>
            <volume>16</volume>
            <fpage>19</fpage>
            <pub-id pub-id-type="pmid">27437106</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Michelow</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pantanowitz</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>A review of the cytomorphology of Epstein-Barr virus-associated malignancies.</article-title>
            <source>Acta Cytol</source>
            <year>2012</year>
            <volume>56</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-14</page-range>
            <pub-id pub-id-type="pmid">22236740</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Henle</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Henle</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Diehl</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>1968</year>
            <month>Jan</month>
            <volume>59</volume>
            <issue>1</issue>
            <fpage>94</fpage>
            <page-range>94-101</page-range>
            <pub-id pub-id-type="pmid">5242134</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nguyen</surname>
                <given-names>ADK</given-names>
              </name>
              <name>
                <surname>Siu</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kleinschmidt</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sood</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Shandiz</surname>
                <given-names>EE</given-names>
              </name>
            </person-group>
            <article-title>Epstein-Barr virus reactivation-related meningoencephalitis with transverse myelitis in pregnancy.</article-title>
            <source>Clin Case Rep</source>
            <year>2023</year>
            <month>Sep</month>
            <volume>11</volume>
            <issue>9</issue>
            <fpage>e7923</fpage>
            <pub-id pub-id-type="pmid">37744622</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sausen</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Bhutta</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Gallo</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Dahari</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Borenstein</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Stress-Induced Epstein-Barr Virus Reactivation.</article-title>
            <source>Biomolecules</source>
            <year>2021</year>
            <month>Sep</month>
            <day>18</day>
            <volume>11</volume>
            <issue>9</issue>
            <pub-id pub-id-type="pmid">34572593</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Henle</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Evidence for viruses in acute leukemia and Burkitt's tumor.</article-title>
            <source>Cancer</source>
            <year>1968</year>
            <month>Apr</month>
            <volume>21</volume>
            <issue>4</issue>
            <fpage>580</fpage>
            <page-range>580-6</page-range>
            <pub-id pub-id-type="pmid">4868472</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cohen</surname>
                <given-names>JI</given-names>
              </name>
            </person-group>
            <article-title>Epstein-Barr virus infection.</article-title>
            <source>N Engl J Med</source>
            <year>2000</year>
            <month>Aug</month>
            <day>17</day>
            <volume>343</volume>
            <issue>7</issue>
            <fpage>481</fpage>
            <page-range>481-92</page-range>
            <pub-id pub-id-type="pmid">10944566</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dowd</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Palermo</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Brite</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>McDade</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Aiello</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Seroprevalence of Epstein-Barr virus infection in U.S. children ages 6-19, 2003-2010.</article-title>
            <source>PLoS One</source>
            <year>2013</year>
            <volume>8</volume>
            <issue>5</issue>
            <fpage>e64921</fpage>
            <pub-id pub-id-type="pmid">23717674</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharifipour</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Davoodi Rad</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Seroprevalence of Epstein-Barr virus among children and adults in Tehran, Iran.</article-title>
            <source>New Microbes New Infect</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>34</volume>
            <fpage>100641</fpage>
            <pub-id pub-id-type="pmid">32025310</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuri</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jacobs</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Vickaryous</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Pakpoor</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Middeldorp</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Giovannoni</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Dobson</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom.</article-title>
            <source>BMC Public Health</source>
            <year>2020</year>
            <month>Jun</month>
            <day>12</day>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>912</fpage>
            <pub-id pub-id-type="pmid">32532296</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gares</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Panico</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Castagne</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Delpierre</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kelly-Irving</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The role of the early social environment on Epstein Barr virus infection: a prospective observational design using the Millennium Cohort Study.</article-title>
            <source>Epidemiol Infect</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>145</volume>
            <issue>16</issue>
            <fpage>3405</fpage>
            <page-range>3405-3412</page-range>
            <pub-id pub-id-type="pmid">29202893</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ace</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Domb</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Myocarditis as the initial presentation of Epstein-Barr virus infection in a 17-year-old male patient.</article-title>
            <source>Can Fam Physician</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>65</volume>
            <issue>12</issue>
            <fpage>897</fpage>
            <page-range>897-899</page-range>
            <pub-id pub-id-type="pmid">31831489</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Binkley</surname>
                <given-names>PF</given-names>
              </name>
              <name>
                <surname>Cooke</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Lesinski</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Laskowski</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Waldman</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Ariza</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Knight</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Glaser</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Evidence for the role of Epstein Barr Virus infections in the pathogenesis of acute coronary events.</article-title>
            <source>PLoS One</source>
            <year>2013</year>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>e54008</fpage>
            <pub-id pub-id-type="pmid">23349778</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chimenti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Russo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pieroni</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Calabrese</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Verardo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Thiene</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Russo</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Maseri</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Frustaci</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Intramyocyte detection of Epstein-Barr virus genome by laser capture microdissection in patients with inflammatory cardiomyopathy.</article-title>
            <source>Circulation</source>
            <year>2004</year>
            <month>Dec</month>
            <day>07</day>
            <volume>110</volume>
            <issue>23</issue>
            <fpage>3534</fpage>
            <page-range>3534-9</page-range>
            <pub-id pub-id-type="pmid">15557377</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sole</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Viral myocarditis: a paradigm for understanding the pathogenesis and treatment of dilated cardiomyopathy.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>1993</year>
            <month>Oct</month>
            <volume>22</volume>
            <issue>4 Suppl A</issue>
            <fpage>99A</fpage>
            <page-range>99A-105A</page-range>
            <pub-id pub-id-type="pmid">8376702</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sozzi</surname>
                <given-names>FB</given-names>
              </name>
              <name>
                <surname>Gherbesi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Faggiano</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gnan</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Maruccio</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schiavone</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Iacuzio</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Carugo</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Viral Myocarditis: Classification, Diagnosis, and Clinical Implications.</article-title>
            <source>Front Cardiovasc Med</source>
            <year>2022</year>
            <volume>9</volume>
            <fpage>908663</fpage>
            <pub-id pub-id-type="pmid">35795363</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aretz</surname>
                <given-names>HT</given-names>
              </name>
              <name>
                <surname>Billingham</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Factor</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Fallon</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Fenoglio</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Olsen</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Schoen</surname>
                <given-names>FJ</given-names>
              </name>
            </person-group>
            <article-title>Myocarditis. A histopathologic definition and classification.</article-title>
            <source>Am J Cardiovasc Pathol</source>
            <year>1987</year>
            <month>Jan</month>
            <volume>1</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-14</page-range>
            <pub-id pub-id-type="pmid">3455232</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cooper</surname>
                <given-names>LT</given-names>
              </name>
            </person-group>
            <article-title>Myocarditis.</article-title>
            <source>N Engl J Med</source>
            <year>2009</year>
            <month>Apr</month>
            <day>09</day>
            <volume>360</volume>
            <issue>15</issue>
            <fpage>1526</fpage>
            <page-range>1526-38</page-range>
            <pub-id pub-id-type="pmid">19357408</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>ElAmm</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Al-Kindi</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Oliveira</surname>
                <given-names>GH</given-names>
              </name>
            </person-group>
            <article-title>Characteristics and Outcomes of Patients With Myocarditis Listed for Heart Transplantation.</article-title>
            <source>Circ Heart Fail</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>9</volume>
            <issue>12</issue>
            <pub-id pub-id-type="pmid">27927755</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharif</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Dehghani</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Emergency files: acute pericarditis, myocarditis, and worse!</article-title>
            <source>Can Fam Physician</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>59</volume>
            <issue>1</issue>
            <fpage>39</fpage>
            <page-range>39-41</page-range>
            <pub-id pub-id-type="pmid">23341656</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Olejniczak</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Webber</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Shaffer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Perry</surname>
                <given-names>TE</given-names>
              </name>
            </person-group>
            <article-title>Viral Myocarditis-Incidence, Diagnosis and Management.</article-title>
            <source>J Cardiothorac Vasc Anesth</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>34</volume>
            <issue>6</issue>
            <fpage>1591</fpage>
            <page-range>1591-1601</page-range>
            <pub-id pub-id-type="pmid">32127272</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roubille</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gahide</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Moore-Morris</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Granier</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Davy</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Vernhet</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Piot</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Epstein Barr virus (EBV) and acute myopericarditis in an immunocompetent patient: first demonstrated case and discussion.</article-title>
            <source>Intern Med</source>
            <year>2008</year>
            <volume>47</volume>
            <issue>7</issue>
            <fpage>627</fpage>
            <page-range>627-9</page-range>
            <pub-id pub-id-type="pmid">18379149</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fung</surname>
                <given-names>RCM</given-names>
              </name>
              <name>
                <surname>Hon</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Leung</surname>
                <given-names>AKC</given-names>
              </name>
            </person-group>
            <article-title>Acute Myocarditis in Children: An Overview of Treatment and Recent Patents.</article-title>
            <source>Recent Pat Inflamm Allergy Drug Discov</source>
            <year>2020</year>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>106</fpage>
            <page-range>106-116</page-range>
            <pub-id pub-id-type="pmid">32013855</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dec</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Waldman</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Southern</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fallon</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Hutter</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Palacios</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Viral myocarditis mimicking acute myocardial infarction.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>1992</year>
            <month>Jul</month>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>85</fpage>
            <page-range>85-9</page-range>
            <pub-id pub-id-type="pmid">1607543</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harris</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Mackey-Bojack</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bennett</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nwaudo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Duncanson</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Maron</surname>
                <given-names>BJ</given-names>
              </name>
            </person-group>
            <article-title>Sudden Unexpected Death Due to Myocarditis in Young People, Including Athletes.</article-title>
            <source>Am J Cardiol</source>
            <year>2021</year>
            <month>Mar</month>
            <day>15</day>
            <volume>143</volume>
            <fpage>131</fpage>
            <page-range>131-134</page-range>
            <pub-id pub-id-type="pmid">33347841</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schultz</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Hilliard</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Rihal</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and treatment of viral myocarditis.</article-title>
            <source>Mayo Clin Proc</source>
            <year>2009</year>
            <month>Nov</month>
            <volume>84</volume>
            <issue>11</issue>
            <fpage>1001</fpage>
            <page-range>1001-9</page-range>
            <pub-id pub-id-type="pmid">19880690</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ammirati</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Moslehi</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and Treatment of Acute Myocarditis: A Review.</article-title>
            <source>JAMA</source>
            <year>2023</year>
            <month>Apr</month>
            <day>04</day>
            <volume>329</volume>
            <issue>13</issue>
            <fpage>1098</fpage>
            <page-range>1098-1113</page-range>
            <pub-id pub-id-type="pmid">37014337</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kyaw</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Drummond</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bobik</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Peter</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Myocarditis: causes, mechanisms, and evolving therapies.</article-title>
            <source>Expert Opin Ther Targets</source>
            <year>2023</year>
            <month>Mar</month>
            <volume>27</volume>
            <issue>3</issue>
            <fpage>225</fpage>
            <page-range>225-238</page-range>
            <pub-id pub-id-type="pmid">36946552</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adegbala</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Olagoke</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Akintoye</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Adejumo</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Oluwole</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jara</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Briasoulis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Afonso</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Predictors, Burden, and the Impact of Arrhythmia on Patients Admitted for Acute Myocarditis.</article-title>
            <source>Am J Cardiol</source>
            <year>2019</year>
            <month>Jan</month>
            <day>01</day>
            <volume>123</volume>
            <issue>1</issue>
            <fpage>139</fpage>
            <page-range>139-144</page-range>
            <pub-id pub-id-type="pmid">30539745</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marshall-Andon</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Heinz</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>How to use &#x02026; the Monospot and other heterophile antibody tests.</article-title>
            <source>Arch Dis Child Educ Pract Ed</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>102</volume>
            <issue>4</issue>
            <fpage>188</fpage>
            <page-range>188-193</page-range>
            <pub-id pub-id-type="pmid">28130396</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Womack</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jimenez</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Common questions about infectious mononucleosis.</article-title>
            <source>Am Fam Physician</source>
            <year>2015</year>
            <month>Mar</month>
            <day>15</day>
            <volume>91</volume>
            <issue>6</issue>
            <fpage>372</fpage>
            <page-range>372-6</page-range>
            <pub-id pub-id-type="pmid">25822555</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jiang</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Shao</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Liao</surname>
                <given-names>XL</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>ZH</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Real-time polymerase chain reaction for diagnosing infectious mononucleosis in pediatric patients: A systematic review and meta-analysis.</article-title>
            <source>J Med Virol</source>
            <year>2016</year>
            <month>May</month>
            <volume>88</volume>
            <issue>5</issue>
            <fpage>871</fpage>
            <page-range>871-6</page-range>
            <pub-id pub-id-type="pmid">26455510</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ryan</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Fan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Glaser</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Schichman</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Raab-Traub</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Gulley</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Epstein-Barr virus quantitation by real-time PCR targeting multiple gene segments: a novel approach to screen for the virus in paraffin-embedded tissue and plasma.</article-title>
            <source>J Mol Diagn</source>
            <year>2004</year>
            <month>Nov</month>
            <volume>6</volume>
            <issue>4</issue>
            <fpage>378</fpage>
            <page-range>378-85</page-range>
            <pub-id pub-id-type="pmid">15507678</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haque</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Crawford</surname>
                <given-names>DH</given-names>
              </name>
            </person-group>
            <article-title>PCR amplification is more sensitive than tissue culture methods for Epstein-Barr virus detection in clinical material.</article-title>
            <source>J Gen Virol</source>
            <year>1997</year>
            <month>Dec</month>
            <volume>78 ( Pt 12)</volume>
            <fpage>3357</fpage>
            <page-range>3357-60</page-range>
            <pub-id pub-id-type="pmid">9400988</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lampejo</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Durkin</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Bhatt</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Guttmann</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Acute myocarditis: aetiology, diagnosis and management.</article-title>
            <source>Clin Med (Lond)</source>
            <year>2021</year>
            <month>Sep</month>
            <volume>21</volume>
            <issue>5</issue>
            <fpage>e505</fpage>
            <page-range>e505-e510</page-range>
            <pub-id pub-id-type="pmid">34507935</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r44">
          <label>44</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Manda</surname>
                <given-names>YR</given-names>
              </name>
              <name>
                <surname>Baradhi</surname>
                <given-names>KM</given-names>
              </name>
            </person-group>
            <chapter-title>Myopericarditis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>17</day>
            <pub-id pub-id-type="pmid">30521197</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marinella</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Electrocardiographic manifestations and differential diagnosis of acute pericarditis.</article-title>
            <source>Am Fam Physician</source>
            <year>1998</year>
            <month>Feb</month>
            <day>15</day>
            <volume>57</volume>
            <issue>4</issue>
            <fpage>699</fpage>
            <page-range>699-704</page-range>
            <pub-id pub-id-type="pmid">9490993</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Watanabe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Panetta</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Piccirillo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Spoto</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Myers</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Serino</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Costantino</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Di Sciascio</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Acute Epstein-Barr related myocarditis: An unusual but life-threatening disease in an immunocompetent patient.</article-title>
            <source>J Cardiol Cases</source>
            <year>2020</year>
            <month>Apr</month>
            <volume>21</volume>
            <issue>4</issue>
            <fpage>137</fpage>
            <page-range>137-140</page-range>
            <pub-id pub-id-type="pmid">32256861</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rahman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Pericarditis - clinical features and management.</article-title>
            <source>Aust Fam Physician</source>
            <year>2011</year>
            <month>Oct</month>
            <volume>40</volume>
            <issue>10</issue>
            <fpage>791</fpage>
            <page-range>791-6</page-range>
            <pub-id pub-id-type="pmid">22003482</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pinamonti</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Alberti</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cigalotto</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dreas</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Salvi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Silvestri</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Camerini</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Echocardiographic findings in myocarditis.</article-title>
            <source>Am J Cardiol</source>
            <year>1988</year>
            <month>Aug</month>
            <day>01</day>
            <volume>62</volume>
            <issue>4</issue>
            <fpage>285</fpage>
            <page-range>285-91</page-range>
            <pub-id pub-id-type="pmid">3400607</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r49">
          <label>49</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Al-Akchar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shams</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kiel</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <chapter-title>Acute Myocarditis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>5</day>
            <pub-id pub-id-type="pmid">28722877</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferreira</surname>
                <given-names>VM</given-names>
              </name>
              <name>
                <surname>Schulz-Menger</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Holmvang</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kramer</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Carbone</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Sechtem</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Kindermann</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Gutberlet</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Friedrich</surname>
                <given-names>MG</given-names>
              </name>
            </person-group>
            <article-title>Cardiovascular Magnetic Resonance in Nonischemic&#x000a0;Myocardial Inflammation: Expert Recommendations.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2018</year>
            <month>Dec</month>
            <day>18</day>
            <volume>72</volume>
            <issue>24</issue>
            <fpage>3158</fpage>
            <page-range>3158-3176</page-range>
            <pub-id pub-id-type="pmid">30545455</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Greulich</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Seitz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>KAL</given-names>
              </name>
              <name>
                <surname>Gr&#x000fc;n</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ong</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ebadi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kreisselmeier</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Seizer</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bekeredjian</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Zwadlo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gr&#x000e4;ni</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Klingel</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gawaz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sechtem</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Mahrholdt</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Predictors of Mortality in Patients With Biopsy-Proven Viral Myocarditis: 10-Year Outcome Data.</article-title>
            <source>J Am Heart Assoc</source>
            <year>2020</year>
            <month>Aug</month>
            <day>18</day>
            <volume>9</volume>
            <issue>16</issue>
            <fpage>e015351</fpage>
            <pub-id pub-id-type="pmid">32787653</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cooper</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Baughman</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Frustaci</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jessup</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kuhl</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>GN</given-names>
              </name>
              <name>
                <surname>Narula</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Starling</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Towbin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Virmani</surname>
                <given-names>R</given-names>
              </name>
              <collab>American Heart Association</collab>
              <collab>American College of Cardiology</collab>
              <collab>European Society of Cardiology</collab>
            </person-group>
            <article-title>The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology.</article-title>
            <source>Circulation</source>
            <year>2007</year>
            <month>Nov</month>
            <day>06</day>
            <volume>116</volume>
            <issue>19</issue>
            <fpage>2216</fpage>
            <page-range>2216-33</page-range>
            <pub-id pub-id-type="pmid">17959655</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cooper</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Baughman</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Frustaci</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jessup</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kuhl</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>GN</given-names>
              </name>
              <name>
                <surname>Narula</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Starling</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Towbin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Virmani</surname>
                <given-names>R</given-names>
              </name>
              <collab>American Heart Association</collab>
              <collab>American College of Cardiology</collab>
              <collab>European Society of Cardiology</collab>
              <collab>Heart Failure Society of America</collab>
              <collab>Heart Failure Association of the European Society of Cardiology</collab>
            </person-group>
            <article-title>The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2007</year>
            <month>Nov</month>
            <day>06</day>
            <volume>50</volume>
            <issue>19</issue>
            <fpage>1914</fpage>
            <page-range>1914-31</page-range>
            <pub-id pub-id-type="pmid">17980265</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Imazio</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brucato</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Spodick</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Adler</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Prognosis of myopericarditis as determined from previously published reports.</article-title>
            <source>J Cardiovasc Med (Hagerstown)</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>15</volume>
            <issue>12</issue>
            <fpage>835</fpage>
            <page-range>835-9</page-range>
            <pub-id pub-id-type="pmid">24850499</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsch&#x000f6;pe</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Torre-Amione</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Van Linthout</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Management of Myocarditis-Related Cardiomyopathy in Adults.</article-title>
            <source>Circ Res</source>
            <year>2019</year>
            <month>May</month>
            <day>24</day>
            <volume>124</volume>
            <issue>11</issue>
            <fpage>1568</fpage>
            <page-range>1568-1583</page-range>
            <pub-id pub-id-type="pmid">31120823</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Caforio</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Pankuweit</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Arbustini</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Basso</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gimeno-Blanes</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Felix</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Fu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Heli&#x000f6;</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Heymans</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jahns</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Klingel</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Linhart</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Maisch</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>McKenna</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Mogensen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pinto</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Ristic</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schultheiss</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>Seggewiss</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tavazzi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Thiene</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Yilmaz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Charron</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Elliott</surname>
                <given-names>PM</given-names>
              </name>
              <collab>European Society of Cardiology Working Group on Myocardial and Pericardial Diseases</collab>
            </person-group>
            <article-title>Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.</article-title>
            <source>Eur Heart J</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>34</volume>
            <issue>33</issue>
            <fpage>2636</fpage>
            <page-range>2636-48, 2648a-2648d</page-range>
            <pub-id pub-id-type="pmid">23824828</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McMurray</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Adamopoulos</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Anker</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Auricchio</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>B&#x000f6;hm</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dickstein</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Falk</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Filippatos</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fonseca</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gomez-Sanchez</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Jaarsma</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kober</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lip</surname>
                <given-names>GY</given-names>
              </name>
              <name>
                <surname>Maggioni</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Parkhomenko</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pieske</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Popescu</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Ronnevik</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rutten</surname>
                <given-names>FH</given-names>
              </name>
              <name>
                <surname>Schwitter</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Seferovic</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Stepinska</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Trindade</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Voors</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Zannad Falez</surname>
              </name>
              <name>
                <surname>Zeiher</surname>
                <given-names>A</given-names>
              </name>
              <collab>Avrupa Kardiyoloji Derne&#x0011f;i (ESC) Akut ve Kronik Kalp Yetersizli&#x0011f;i Tani ve Tedavisi 2012 G&#x000f6;rev Grubu</collab>
              <collab>ESC Kalp Yetersizli&#x0011f;i Birli&#x0011f;inin I&#x0015f;birli&#x0011f;iyle hazirlanmi&#x0015f;tir</collab>
              <collab>Heart Failure Association</collab>
            </person-group>
            <article-title>[ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012].</article-title>
            <source>Turk Kardiyol Dern Ars</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>40 Suppl 3</volume>
            <fpage>77</fpage>
            <page-range>77-137</page-range>
            <pub-id pub-id-type="pmid">27305718</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lampejo</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Caution with the use of NSAIDs in myocarditis.</article-title>
            <source>QJM</source>
            <year>2023</year>
            <month>Feb</month>
            <day>24</day>
            <volume>116</volume>
            <issue>2</issue>
            <fpage>153</fpage>
            <pub-id pub-id-type="pmid">35289907</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patriki</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Baltensperger</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Berg</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Kissel</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Kottwitz</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lovrinovic</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Manka</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Scherff</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Schmied</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tanner</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Luescher</surname>
                <given-names>TF</given-names>
              </name>
              <name>
                <surname>Heidecker</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>A Prospective Pilot Study to Identify a Myocarditis Cohort who may Safely Resume Sports Activities 3&#x000a0;Months after Diagnosis.</article-title>
            <source>J Cardiovasc Transl Res</source>
            <year>2021</year>
            <month>Aug</month>
            <volume>14</volume>
            <issue>4</issue>
            <fpage>670</fpage>
            <page-range>670-673</page-range>
            <pub-id pub-id-type="pmid">32367345</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maisch</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Alter</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Treatment options in myocarditis and inflammatory cardiomyopathy : Focus on i.&#x0202f;v. immunoglobulins.</article-title>
            <source>Herz</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>43</volume>
            <issue>5</issue>
            <fpage>423</fpage>
            <page-range>423-430</page-range>
            <pub-id pub-id-type="pmid">29947834</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martino</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sole</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Viral infection and the pathogenesis of dilated cardiomyopathy.</article-title>
            <source>Circ Res</source>
            <year>1994</year>
            <month>Feb</month>
            <volume>74</volume>
            <issue>2</issue>
            <fpage>182</fpage>
            <page-range>182-8</page-range>
            <pub-id pub-id-type="pmid">8293557</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kindermann</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Barth</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mahfoud</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ukena</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lenski</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yilmaz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Klingel</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kandolf</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sechtem</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>B&#x000f6;hm</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Update on myocarditis.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2012</year>
            <month>Feb</month>
            <day>28</day>
            <volume>59</volume>
            <issue>9</issue>
            <fpage>779</fpage>
            <page-range>779-92</page-range>
            <pub-id pub-id-type="pmid">22361396</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bolognesi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bolognesi</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Acute coronary syndrome <italic>vs.</italic> myopericarditis - not always a straightforward diagnosis.</article-title>
            <source>Am J Case Rep</source>
            <year>2013</year>
            <volume>14</volume>
            <fpage>221</fpage>
            <page-range>221-225</page-range>
            <pub-id pub-id-type="pmid">23826474</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>P&#x000e9;rez-Molina</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Molina</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Chagas disease.</article-title>
            <source>Lancet</source>
            <year>2018</year>
            <month>Jan</month>
            <day>06</day>
            <volume>391</volume>
            <issue>10115</issue>
            <fpage>82</fpage>
            <page-range>82-94</page-range>
            <pub-id pub-id-type="pmid">28673423</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bonney</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Engman</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Chagas heart disease pathogenesis: one mechanism or many?</article-title>
            <source>Curr Mol Med</source>
            <year>2008</year>
            <month>Sep</month>
            <volume>8</volume>
            <issue>6</issue>
            <fpage>510</fpage>
            <page-range>510-8</page-range>
            <pub-id pub-id-type="pmid">18781958</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r66">
          <label>66</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Sharma</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Waymack</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <chapter-title>Acute Cardiac Tamponade</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>31</day>
            <pub-id pub-id-type="pmid">30521227</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Andr&#x000e9;oletti</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>L&#x000e9;v&#x000ea;que</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Boulagnon</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Brasselet</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fornes</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Viral causes of human myocarditis.</article-title>
            <source>Arch Cardiovasc Dis</source>
            <year>2009</year>
            <season>Jun-Jul</season>
            <volume>102</volume>
            <issue>6-7</issue>
            <fpage>559</fpage>
            <page-range>559-68</page-range>
            <pub-id pub-id-type="pmid">19664576</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ammirati</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cipriani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Moro</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Raineri</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pini</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sormani</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mantovani</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Varrenti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pedrotti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Conca</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mafrici</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Grosu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Briguglia</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Guglielmetto</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Perego</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Colombo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Caico</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Giannattasio</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Maestroni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Carubelli</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Metra</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lombardi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Campodonico</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Agostoni</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Peretto</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Scelsi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Turco</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Di Tano</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Campana</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Belloni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Morandi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Mortara</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cir&#x000f2;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Senni</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gavazzi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Frigerio</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Oliva</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Camici</surname>
                <given-names>PG</given-names>
              </name>
              <collab>Registro Lombardo delle Miocarditi</collab>
            </person-group>
            <article-title>Clinical Presentation and Outcome in a Contemporary Cohort of Patients With Acute Myocarditis: Multicenter Lombardy Registry.</article-title>
            <source>Circulation</source>
            <year>2018</year>
            <month>Sep</month>
            <day>11</day>
            <volume>138</volume>
            <issue>11</issue>
            <fpage>1088</fpage>
            <page-range>1088-1099</page-range>
            <pub-id pub-id-type="pmid">29764898</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Piccirillo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Watanabe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Di Sciascio</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis, treatment and predictors of prognosis of myocarditis. A narrative review.</article-title>
            <source>Cardiovasc Pathol</source>
            <year>2021</year>
            <season>Sep-Oct</season>
            <volume>54</volume>
            <fpage>107362</fpage>
            <pub-id pub-id-type="pmid">34192559</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rached-D'Astous</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Boukas</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Fournier</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Raboisson</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Dahdah</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Coronary Artery Dilatation in Viral Myocarditis Mimics Coronary Artery Findings in Kawasaki Disease.</article-title>
            <source>Pediatr Cardiol</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>37</volume>
            <issue>6</issue>
            <fpage>1148</fpage>
            <page-range>1148-52</page-range>
            <pub-id pub-id-type="pmid">27233663</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xiao</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Luo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kuang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Chronic active Epstein-Barr virus infection manifesting as coronary artery aneurysm and uveitis.</article-title>
            <source>Virol J</source>
            <year>2020</year>
            <month>Oct</month>
            <day>29</day>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>166</fpage>
            <pub-id pub-id-type="pmid">33121509</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Myers</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Fairweather</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Huber</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Cunningham</surname>
                <given-names>MW</given-names>
              </name>
            </person-group>
            <article-title>Autoimmune myocarditis, valvulitis, and cardiomyopathy.</article-title>
            <source>Curr Protoc Immunol</source>
            <year>2013</year>
            <volume>Chapter 15</volume>
            <fpage>Unit 15.14.1</fpage>
            <page-range>Unit 15.14.1-51</page-range>
            <pub-id pub-id-type="pmid">23564686</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fukuda</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Momoi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Akaihata</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nagasawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mitomo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Aoyagi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Endoh</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hosoya</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary arterial hypertension associated with chronic active Epstein-Barr virus infection.</article-title>
            <source>Pediatr Int</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>57</volume>
            <issue>4</issue>
            <fpage>731</fpage>
            <page-range>731-4</page-range>
            <pub-id pub-id-type="pmid">25809637</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mancio</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bettencourt</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Oliveira</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pires-Morais</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ribeiro</surname>
                <given-names>VG</given-names>
              </name>
            </person-group>
            <article-title>Acute right ventricular myocarditis presenting with chest pain and syncope.</article-title>
            <source>BMJ Case Rep</source>
            <year>2013</year>
            <month>Oct</month>
            <day>04</day>
            <volume>2013</volume>
            <pub-id pub-id-type="pmid">24096068</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kiamanesh</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Toma</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The State of the Heart Biopsy: A Clinical Review.</article-title>
            <source>CJC Open</source>
            <year>2021</year>
            <month>Apr</month>
            <volume>3</volume>
            <issue>4</issue>
            <fpage>524</fpage>
            <page-range>524-531</page-range>
            <pub-id pub-id-type="pmid">34027357</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145596.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Altman</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Parks</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Schlett</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Orencole</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>MY</given-names>
              </name>
              <name>
                <surname>Truong</surname>
                <given-names>QA</given-names>
              </name>
              <name>
                <surname>Deeprasertkul</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Barrett</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Upadhyay</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Heist</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Picard</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Multidisciplinary care of patients receiving cardiac resynchronization therapy is associated with improved clinical outcomes.</article-title>
            <source>Eur Heart J</source>
            <year>2012</year>
            <month>Sep</month>
            <volume>33</volume>
            <issue>17</issue>
            <fpage>2181</fpage>
            <page-range>2181-8</page-range>
            <pub-id pub-id-type="pmid">22613342</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
